CLINICAL_TRIALS
trial_result
· 2011-09-16
Clinical Trial Update: Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating clofarabine in combination with rituximab for relapsed non-Hodgkin lymphoma; study terminated with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OHSU Knight Cancer Institute | Conditions: Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-09-16